Orange Book product · Generic (ANDA)
LEUCOVORIN CALCIUM PRESERVATIVE FREE
LEUCOVORIN CALCIUM
At a glance
May 19, 2017
Approved
Generic (ANDA)
Application
AP
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
May 19, 2017
9 yr 3 mo ago
Today
Pharmaceutical detail
Active ingredient
LEUCOVORIN CALCIUM
Strength
EQ 100MG BASE/VIAL
Dosage form
INJECTABLE
Route
INJECTION
TE code
AP
Application
ANDA 203800
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of LEUCOVORIN CALCIUM
- 2026VYKOURABrand (NDA)
NDA 220406 · AVYXA HOLDINGS
- 1987LEUCOVORIN CALCIUMBrand (NDA)
NDA 008107 · HOSPIRA
- 2025LEUCOVORIN CALCIUMGeneric (ANDA)
ANDA 218200 · GLAND
- 2023LEUCOVORIN CALCIUMGeneric (ANDA)
ANDA 216590 · MEITHEAL
- 2023LEUCOVORIN CALCIUMGeneric (ANDA)
ANDA 217021 · HAINAN POLY
- 2020LEUCOVORIN CALCIUMGeneric (ANDA)
ANDA 213929 · LEADING
- 2020LEUCOVORIN CALCIUMGeneric (ANDA)
ANDA 211132 · INGENUS PHARMS LLC
- 2018LEUCOVORIN CALCIUMGeneric (ANDA)
ANDA 210917 · INGENUS PHARMS LLC
- 2018LEUCOVORIN CALCIUMGeneric (ANDA)
ANDA 207226 · FRESENIUS KABI USA
- 2018LEUCOVORIN CALCIUMGeneric (ANDA)
ANDA 207241 · FRESENIUS KABI USA
- 2017LEUCOVORIN CALCIUM PRESERVATIVE FREEGeneric (ANDA)
ANDA 209110 · SAGENT PHARMS INC
- 2012LEUCOVORIN CALCIUM PRESERVATIVE FREEGeneric (ANDA)
ANDA 200753 · SAGENT PHARMS
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
